<HTML><HEAD><TITLE>iridocorneal endothelial syndrome</TITLE>
<META NAME="GENERATOR" CONTENT="Microsoft FrontPage 6.0"></HEAD>
<BODY BACKGROUND="Graphics/Cheetah.jpg">
<p><font size="5" color="#FF00FF"><b>Iridocorneal endothelial syndrome</b></font></p>
<p><font size="4" face="Times New Roman" color="#0000FF">* </font>
<font face="Times New Roman" color="#CC3300" size="4">&#272;&#7883;nh ngh&#297;a</font><font size="4" face="Times New Roman" color="#0000FF">:</font></p>
<blockquote>
	<p><font color="#0000FF" size="4">+ H&#7897;i ch&#7913;ng m&#7889;ng m&#7855;t - giác m&#7841;c - n&#7897;i mô</font></p>
	<p align="center">
	<img border="0" src="Images/deseases/iris%20and%20ciliary%20body/Essential%20Iris%20Atrophy.jpg" width="432" height="307"></p>
</blockquote>
<p><font size="4" face="Times New Roman" color="#0000FF">* </font>
<font face="Times New Roman" color="#CC3300" size="4">&#272;&#7863;c &#273;i&#7875;m</font><font size="4" face="Times New Roman" color="#0000FF">:</font></p>
<blockquote>
	<p><font face="Times New Roman" size="4" color="#0000FF">+ H&#7897;i ch&#7913;ng này là 
	g&#7891;m 3 h&#7897;i ch&#7913;ng xen l&#7851;n nhau: <i><b>Teo m&#7889;ng m&#7855;t vô c&#259;n, Chandler, và nevus 
	m&#7889;ng m&#7855;t (Cogan-Reese)</b></i> mà chúng cùng gây ra nh&#7919;ng b&#7845;t th&#432;&#7901;ng l&#7899;p t&#7871; 
	bào n&#7897;i mô giác m&#7841;c, có th&#7875; lan ra góc ti&#7873;n phòng. Góc &#273;óng th&#7913; phát có th&#7875; 
	do co kéo nh&#7919;ng mô này</font></p>
	<p><font face="Times New Roman" size="4" color="#0000FF">+ &#272;&#7885;c thêm:</font></p>
	<p><b><font color="#CC3300" size="4">IRIDOCORNEAL ENDOTHELIAL SYNDROME</font></b></p>
	<ul>
		<li><font color="#0000FF" size="4">DEFINITION<br>
		Three overlapping syndromes—essential iris atrophy, Chandler, and iris 
		nevus (Cogan–Reese)—that share an abnormal corneal endothelial cell 
		layer, which can grow across the anterior chamber angle. Secondary angle 
		closure can result from contraction of this tissue.<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4">SYMPTOMS<br>
		Asymptomatic in its early stages. Later, the patient notes an irregular 
		iris appearance, blurred vision, or pain in one eye. Patients are 
		typically young to middle-aged adults. Familial cases are extremely 
		rare.<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4">SIGNS<br>
		Critical. Corneal endothelial changes (fine, hammered-metal appearance) 
		localized, irregular PAS that often extend beyond Schwalbe line, deep 
		central anterior chamber, unilaterality, and iris alterations as 
		follows:<br>
		<br>
		<b><i>Essential iris atrophy</i></b>: Marked iris thinning often leading 
		to iris holes and displacement and distortion of the pupil.<br>
		<br>
		<b><i>Chandler syndrome</i></b>: Mild iris thinning and pupil 
		distortion. The corneal changes are most marked in this variant. 
		Patients often have corneal edema even at normal IOP.<br>
		<br>
		<b><i>Cogan–Reese syndrome</i></b>: Pigmented nodules on the iris 
		surface, variable iris atrophy. The iris changes may also be seen in 
		Chandler syndrome and essential iris atrophy.<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4">Other. Corneal edema, elevated IOP, 
		optic nerve cupping, or visual field loss. Typically unilateral, 
		although mild corneal changes consistent with this syndrome are 
		sometimes found in the contralateral eye. However, the glaucoma is 
		nearly always unilateral.<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4">DIFFERENTIAL DIAGNOSIS<br>
		<i>Axenfeld–Rieger syndrome</i> [Prominent, anteriorly displaced 
		Schwalbe line (posterior embryotoxon), peripheral iris strands extending 
		to Schwalbe line, iris thinning with atrophic holes, may have dental, 
		craniofacial, and skeletal abnormalities. Bilateral and congenital. See 
		8.12, Developmental Anterior Segment and Lens Anomalies.].<br>
		<br>
		<i>Posterior polymorphous dystrophy</i> (Bilateral. Endothelial vesicles 
		or bandlike lesions, occasionally associated with iridocorneal 
		adhesions, corneal edema, and glaucoma. See 4.24, Corneal Dystrophies.).<br>
		<br>
		<i>Fuchs endothelial dystrophy</i> (Bilateral corneal edema and 
		endothelial guttata. The iris and anterior chamber angle are normal. See 
		4.25, Fuchs Endothelial Dystrophy.).<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4"><i>Iris melanoma </i>(Pigmented iris 
		lesion or lesions noted to enlarge over time. See 5.13, Malignant 
		Melanoma of the Iris.).<br>
		<br>
		Prior uveitis (Pigmented keratic precipitates, posterior synechiae, 
		cataract.).<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4">WORKUP<br>
		1.Family history: ICE syndrome is not inherited; Axenfeld–Rieger 
		syndrome and posterior polymorphous dystrophy are often autosomal 
		dominant.<br>
		<br>
		2.Slit-lamp examination: Assess the cornea and iris and measure IOP.<br>
		<br>
		3.Gonioscopy of the anterior chamber angle.<br>
		<br>
		4.Optic nerve examination.<br>
		<br>
		5.Slit-lamp photos and stereoscopic disc photographs or image analysis.<br>
		<br>
		6.Visual field test, preferably automated (e.g., Humphrey, Octopus).<br>
		<br>
		7.Consider obtaining corneal endothelial specular microscopy.<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4">TREATMENT<br>
		No treatment is needed unless glaucoma or corneal edema is present, at 
		which point one or more of the following treatments is used:<br>
		<br>
		1.Antiglaucomatous medications for corneal edema or glaucoma (see 9.1, 
		Primary Open-Angle Glaucoma). The IOP may need to be reduced beneath a 
		critical level to rid the cornea of edema. This critical level may 
		become lower as the patient ages.<br>
		2.Hypertonic saline solutions (e.g., sodium chloride, 5% drops, q.i.d., 
		and ointment, q.h.s.) may help to reduce corneal edema.<br>
		3.Consider filtering procedure (tube shunt or trabeculectomy) when 
		medical therapy fails to maintain the IOP low enough to prevent corneal 
		edema or progression of optic nerve damage. Laser trabeculoplasty and 
		laser PI are ineffective.<br>
		4.Consider a corneal transplant in cases of advanced chronic corneal 
		edema in the presence of good IOP control.<br>
&nbsp;</font></li>
		<li><font color="#0000FF" size="4">FOLLOW-UP<br>
		Depends on the level of IOP and state of the nerve. If asymptomatic with 
		healthy optic nerve, may see every 12 months. If glaucoma is present, 
		then every 1 to 3 months, depending on the severity of the glaucoma.<br>
&nbsp;</font></li>
	</ul>
</blockquote>

</BODY></HTML>